Carmelo Blanquicett, MD

Cancer Focus:
Colon Cancer, Pancreatic Cancer

Dr. Blanquicett received his MD degree from Meharry Medical College, Nashville, Tennessee, and his PhD in Pharmacology and Toxicology from the University of Alabama at Birmingham (UAB). He also completed an Internal Medicine Residency at UAB. Dr. Blanquicett then completed a Geriatric Medicine Fellowship at Emory University School of Medicine, Atlanta, Georgia, where he was a faculty member before pursuing a Hematology/ Oncology Fellowship at the University of South Florida/Moffitt Cancer Center. Post fellowship at USF/Moffitt, Dr. Blanquicett served as a Medical Officer for the Gastrointestinal Oncology Section at the US FDA until 2023, when he returned to Florida for a medical oncology practice opportunity in St. Petersburg. He currently serves part-time in the US Air Force as Chief of Hospital Medicine and as a Flight Surgeon at Dobbins Air Reserve Base, in Atlanta, GA. 

Dr. Blanquicett’s clinical interests are gastrointestinal malignancies and geriatric oncology, with a particular focus on pancreatic and colorectal cancer patients. His research interests encompass using genomic approaches to tailor therapies for individuals with gastrointestinal cancers as well as identifying variables that influence treatment response and toxicity in geriatric oncology patients.

• Lee JJ, Aboujaoude M, Oraiqat A, Horiuchi T, Goodchild S, Jacobsen T, Blanquicett C, Frakes J, Nardella N, Hodul P, Hoffe S. CLO26-076: Prognostic Outcomes in Resected Pancreatic Cancer Treated With Neoadjuvant Chemotherapy Alone: Impact of Integrated Pathologic Score. J Natl Compr Canc Ne. 2026 Mar.24(3.5). Pubmedid: 42061429.
• Lee JJ, Aboujaoude M, Oraiqat A, Horiuchi T, Goodchild S, Jacobsen T, Blanquicett C, Frakes J, Nardella N, Hodul P, Hoffe S. CLO26-076: Prognostic Outcomes in Resected Pancreatic Cancer Treated With Neoadjuvant Chemotherapy Alone: Impact of Integrated Pathologic Score. J Natl Compr Canc Ne. 2026 Mar.24(3.5). Pubmedid: 41911720.
• Moravec S, Barton LV, Suresh R, Hayward L, Schmidlen T, Rivera JNR, Basinski T, Alhassan S, Nardella N, Oraiqat A, Craig L, Cooper L, Blanquicett CJ, Maharaj SS, Blue K, Adams M, Kim R, Biachi De Castria T, Malafa M, Sinnamon AJ, Pereira AL, Kim DW, Hoffe S, Hodul PJ, Vadaparampil ST, Ho TT, Hicks JK, Snir M, Permuth JB. Implementing Timely Germline Genetic Testing for Patients With Pancreatic Cancer Using a Genetics Copilot for Point-of-Care Education and Health Assessment. JCO Precis Oncol. 2026 Jun.10(6):e2500807. Pubmedid: 42372208. Pmcid: PMC13366501.
• Gamarra Samaniego MDP, Blanquicett CJ, Araujo Castillo RV, Chavez JC, Beltrán Garate BE. Selected Domains within a Comprehensive Geriatric Assessment in Older Patients with Non-Hodgkin Lymphoma are Highly Associated with Frailty. Clin Hematol Int. 2022 Jun.4(1-2):35-43. Pubmedid: 35950204. Pmcid: PMC9358790.
• Blanquicett CJ, Aguirre LE. Therapeutic Advances for Pancreatic Cancer: a Slow and Challenging Feat that Continues to Evolve. Acta Sci Gastron Disord. 2021 Jul.4(7):50-52. Pubmedid: 34414366. Pmcid: PMC8372192.
• Blanquicett CJ, Raavi T, Mirk A, Johnson TM, Jaglal M, Cartwright EJ. Outcomes using direct-acting antiviral hepatitis-C treatment in older versus younger Veterans. J Am Geriatr Soc. 2021 Dec.69(12):3602-3607. Pubmedid: 34499744.
• Blanquicett C, Johnson T, Flowers C, Cohen JB. The Role of the Comprehensive Geriatric Assessment in the Evaluation of the Older Cancer Patient. Oncology (Williston Park). 2019 Nov.33(11). Pubmedid: 31769862.
• Blanquicett CJ, Raavi T, Robert SM. A Severe Episode of Hemolytic Anemia After Amoxicillin Exposure in A G6PD Deficient Patient. Arch Clin Med Case Rep. 2019 Jul.3(3):104-112. Pubmedid: 31321386. Pmcid: PMC6637955.
• Blanquicett C, Dunn T, Nanda A, Weber F. An Uncommon Cause of Dysphagia in a 35 Year Old Male. Pract Gastroenterol. 2017 May.41(5):40-42. Pubmedid: 29731535. Pmcid: PMC5933880.
• Launay M, Ciccolini J, Fournel C, Blanquicett C, Dupuis C, Fakhry N, Duffaud F, Salas S, Lacarelle B. UPFRONT DPD DEFICIENCY DETECTION TO SECURE 5-FU ADMINISTRATION: PART 2- APPLICATION TO HEAD-AND-NECK CANCER PATIENTS. Clin Cancer Drugs. 2017 Jan.4(2):122-128. Pubmedid: 29682445. Pmcid: PMC5906055.
• Wu Y, Denny JC, Trent Rosenbloom S, Miller RA, Giuse DA, Wang L, Blanquicett C, Soysal E, Xu J, Xu H. A long journey to short abbreviations: developing an open-source framework for clinical abbreviation recognition and disambiguation (CARD). J Am Med Inform Assoc. 2017 Apr.24(e1):e79-e86. Pubmedid: 27539197. Pmcid: PMC7651947.
• Karnes JH, Cronin RM, Rollin J, Teumer A, Pouplard C, Shaffer CM, Blanquicett C, Bowton EA, Cowan JD, Mosley JD, Van Driest SL, Weeke PE, Wells QS, Bakchoul T, Denny JC, Greinacher A, Gruel Y, Roden DM. A genome-wide association study of heparin-induced thrombocytopenia using an electronic medical record. Thromb Haemostasis. 2015 Apr.113(4):772-781. Pubmedid: 25503805. Pmcid: PMC4433536.
• Blanquicett C, Kang BY, Ritzenthaler JD, Jones DP, Hart CM. Oxidative stress modulates PPAR gamma in vascular endothelial cells. Free Radical Bio Med. 2010 Jun.48(12):1618-1625. Pubmedid: 20302927. Pmcid: PMC2868091.
• Guarcello V, Blanquicett C, Naguib FN, El Kouni MH. Suppression of thymidine phosphorylase expression by promoter methylation in human cancer cells lacking enzyme activity. Cancer Chemother Pharmacol. 2008 Jun.62(1):85-96. Pubmedid: 17805539.
• Blanquicett C, Roman J, Hart CM. Thiazolidinediones as anti-cancer agents. Cancer Ther. 2008 Jan.6(A):25-34. Pubmedid: 19079765. Pmcid: PMC2600565.
• Fanciullino R, Giacometti S, Mercier C, Aubert C, Blanquicett C, Piccerelle P, Ciccolini J. In vitro and in vivo reversal of resistance to 5-fluorouracil in colorectal cancer cells with a novel stealth double-liposomal formulation. Brit J Cancer. 2007 Oct.97(7):919-926. Pubmedid: 17848948. Pmcid: PMC2360412.
• Blanquicett C, Graves A, Kleinhenz DJ, Hart CM. Attenuation of signaling and nitric oxide production following prolonged leptin exposure in human aortic endothelial cells. J Invest Med. 2007 Nov.55(7):368-377. Pubmedid: 18062898.
• Ciccolini J, Mercier C, Evrard A, Dahan L, Boyer JC, Duffaud F, Richard K, Blanquicett C, Milano G, Blesius A, Durand A, Seitz JF, Favre R, Lacarelle B. A rapid and inexpensive method for anticipating severe toxicity to fluorouracil and fluorouracil-based chemotherapy. Ther Drug Monit. 2006 Oct.28(5):678-685. Pubmedid: 17038885.
• Steg A, Wang W, Blanquicett C, Grunda JM, Eltoum IA, Wang K, Buchsbaum DJ, Vickers SM, Russo S, Diasio RB, Frost AR, LoBuglio AF, Grizzle WE, Johnson MR. Multiple gene expression analyses in paraffin-embedded tissues by TaqMan low-density array: Application to hedgehog and Wnt pathway analysis in ovarian endometrioid adenocarcinoma. J Mol Diagn. 2006 Feb.8(1):76-83. Pubmedid: 16436637. Pmcid: PMC1867577.
• Saif MW, Eloubeidi MA, Russo S, Steg A, Thornton J, Fiveash J, Carpenter M, Blanquicett C, Diasio RB, Johnson MR. Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: expression analysis of genes related to outcome. J Clin Oncol. 2005 Dec.23(34):8679-8687. Pubmedid: 16314628.
• Blanquicett C, Saif MW, Buchsbaum DJ, Eloubeidi M, Vickers SM, Chhieng DC, Carpenter MD, Sellers JC, Russo S, Diasio RB, Johnson MR. Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects. Clin Cancer Res. 2005 Dec.11(24 Pt 1):8773-8781. Pubmedid: 16361565.
• Sambandam T, Belousova M, Accaviti-Loper MA, Blanquicett C, Guercello V, Raijmakers R, Nicholas AP. Increased peptidylarginine deiminase type II in hypoxic astrocytes. Biochem Bioph Res Co. 2004 Dec.325(4):1324-1329. Pubmedid: 15555572.
• Blanquicett C, Gillespie GY, Nabors LB, Miller CR, Bharara S, Buchsbaum DJ, Diasio RB, Johnson MR. Induction of thymidine phosphorylase in both irradiated and shielded, contralateral human U87MG glioma xenografts: implications for a dual modality treatment using capecitabine and irradiation. Mol Cancer Ther. 2002 Oct.1(12):1139-1145. Pubmedid: 12481438.
• Blanquicett C, Johnson MR, Heslin M, Diasio RB. Housekeeping gene variability in normal and carcinomatous colorectal and liver tissues: applications in pharmacogenomic gene expression studies. Anal Biochem. 2002 Apr.303(2):209-214. Pubmedid: 11950223.